Form 4 for CRMD CorMedix Inc.
Accepted 2023-11-17 00:00:00 ET · period of report 2023-11-16 · accession 0000929638-23-003170 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-17 | 2023-11-16 | CRMD | Lefkowitz Steven W | Dir | M - OptEx | $2.25 | +15.0K | 75.5K | +25% | +$33.8K |
| D | 2023-11-17 | 2023-11-16 | CRMD | Lefkowitz Steven W | Dir | M - OptEx | $0.00 | -15.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-16 | M | A | 15,000 | $2.25 | 75,498 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy Common Stock) | 2023-11-16 | M | D | 15,000 | $0.00 | 0 | D | $2.25 · — to 2027-06-25 | 15,000 Common Stock | (F2) These stock options, representing a right to purchase 15,000 shares of Common Stock, were granted on June 25, 2017. These stock options are fully vested. |